The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit
The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit
CERRITOS, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI's Chief Executive Officer, will participate in the "Defining the Next Chapter in Value-Based Care" panel at the Leerink Healthcare Transformation Summit in Montecito at 8:30am ET on May 16, 2024.
加利福尼亞州塞裏託斯，2024年5月7日（GLOBE NEWSWIRE）——美國最大的基於價值的腫瘤學診所之一腫瘤學研究所公司（納斯達克股票代碼：TOI）今天宣佈，TOI首席執行官丹尼爾·維爾尼奇博士將參加美國東部時間5月上午8點30分在蒙特西託舉行的Leerink醫療轉型峯會上的 “定義基於價值的護理的下一個篇章” 小組討論 2024 年 16 日。
About The Oncology Institute, Inc.
關於腫瘤研究所有限公司
Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit .
腫瘤學研究所及其附屬公司（納斯達克股票代碼：TOI）成立於2007年，通過在社區環境中提供高度專業化、基於價值的癌症護理來推動腫瘤學發展。TOI爲超過180萬名患者提供尖端的循證癌症護理，包括臨床試驗、輸血和傳統上與最先進的醫療服務組織相關的其他護理提供模式。TOI 擁有 110 多名臨床醫生和 70 多個診所，而且還在不斷增長，正在使腫瘤學向更好的方向發展。欲了解更多信息，請訪問。
Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com
投資者
索爾伯裏戰略傳播
investors@theoncologyinstitute.com
譯文內容由第三人軟體翻譯。